These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11820720)

  • 1. C-erbB-2 oncoprotein in gastric carcinoma: correlation with clinical stage and prognosis.
    Oshima CT; Lanzoni VP; Iriya K; Forones NM
    Int J Biol Markers; 2001; 16(4):250-4. PubMed ID: 11820720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
    Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
    Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of c-erbB-2 protein in gastric carcinomas and lymph-node metastases: is the c-erbB-2 protein really a prognostic indicator?
    Ohguri T; Sato Y; Koizumi W; Saigenji K; Kameya T
    Int J Cancer; 1993 Jan; 53(1):75-9. PubMed ID: 8093216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation.
    Chiu KY; Loke SL; Ho FC
    J Clin Pathol; 1994 Feb; 47(2):117-21. PubMed ID: 7907612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain.
    Lee HR; Kim JH; Uhm HD; Ahn JB; Rha SY; Cho JY; Lee JI; Lee KH; Chung HC; Roh JK; Min JS; Lee KS; Shin DH; Kim BS; Hong SW; Choi JH
    Oncology; 1996; 53(3):192-7. PubMed ID: 8643220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
    Kim JP; Oh ST; Hwang TS; Chi JG
    J Korean Med Sci; 1994 Jun; 9(3):248-53. PubMed ID: 7993593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer.
    Gürel S; Dolar E; Yerci O; Samli B; Oztürk H; Nak SG; Gülten M; Memik F
    J Int Med Res; 1999; 27(2):74-8. PubMed ID: 10446693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma.
    Kuhn EJ; Kurnot RA; Sesterhenn IA; Chang EH; Moul JW
    J Urol; 1993 Nov; 150(5 Pt 1):1427-33. PubMed ID: 8105108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection.
    Motojima K; Furui J; Kohara N; Izawa K; Kanematsu T; Shiku H
    Surgery; 1994 Mar; 115(3):349-54. PubMed ID: 7907434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
    Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH
    J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
    Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
    Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
    Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
    Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma.
    Ghaderi A; Vasei M; Maleck-Hosseini SA; Gharesi-Fard B; Khodami M; Doroudchi M; Modjtahedi H
    Pathol Oncol Res; 2002; 8(4):252-6. PubMed ID: 12579211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-erbB-2 oncoprotein content in gastric cancer and in adjacent mucosa.
    García I; Vizoso F; Andicoechea A; Fernandez P; Suarez C; García-Muñz JL; Allende MT
    Int J Biol Markers; 2000; 15(3):231-4. PubMed ID: 11012099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction.
    Polkowski W; van Sandick JW; Offerhaus GJ; ten Kate FJ; Mulder J; Obertop H; van Lanschot JJ
    Ann Surg Oncol; 1999; 6(3):290-7. PubMed ID: 10340889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma.
    Yonemura Y; Ninomiya I; Ohoyama S; Kimura H; Yamaguchi A; Fushida S; Kosaka T; Miwa K; Miyazaki I; Endou Y
    Cancer; 1991 Jun; 67(11):2914-8. PubMed ID: 1673870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
    Qiu M; Zhou Y; Zhang X; Wang Z; Wang F; Shao J; Lu J; Jin Y; Wei X; Zhang D; Wang F; Li Y; Yang D; Xu R
    BMC Cancer; 2014 Nov; 14():823. PubMed ID: 25380654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.